SLDBHealthcareSmall-Cap
Solid Biosciences Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Solid Biosciences Inc. (SLDB), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are SLDB insiders buying or selling?
Solid Biosciences Inc. insiders reported 10 open-market buys ($90.8M) and 86 sells ($14.2M) across 96 Form 4 filings — a net buying position of $76.6M.
Source: SEC EDGAR Form 4
Key Statistics (as of Feb 19, 2026)
Total Form 4 filings
96
SEC EDGAR
Insider filers
22
Insider buys (10)
$90.8M
Insider sells (86)
$14.2M
Insider sentiment
Net buyingNet insider flow of $76.6M in net buying.
Recent SLDB insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 19, 2026 | Alexander Cumbo | President and CEO | Sale | 16.6K | $5.82 | $96.9K |
| Feb 19, 2026 | Jessie Hanrahan | Chief Regulatory Officer | Sale | 4.1K | $5.82 | $24.1K |
| Feb 19, 2026 | Ilan Ganot | Director | Sale | 2.7K | $5.82 | $15.5K |
| Feb 19, 2026 | Paul Herzich | Chief Technology Officer | Sale | 3.6K | $5.82 | $21.1K |
| Feb 19, 2026 | David T Howton | Chief Operating Officer | Sale | 7.5K | $5.82 | $43.5K |
| Feb 19, 2026 | Kevin Tan | CFO & Treasurer | Sale | 5.4K | $5.82 | $31.5K |
| Feb 6, 2026 | David T Howton | Chief Operating Officer | Sale | 18.9K | $6.44 | $121.7K |
| Feb 6, 2026 | Alexander Cumbo | President and CEO | Sale | 48.9K | $6.44 | $315.1K |
| Feb 6, 2026 | Ilan Ganot | Director | Sale | 7.2K | $6.44 | $46.4K |
| Feb 6, 2026 | Kevin Tan | CFO & Treasurer | Sale | 14.8K | $6.44 | $95.2K |
| Feb 6, 2026 | Gabriel Brooks | Chief Medical Officer | Sale | 12.6K | $6.44 | $81.3K |
| Feb 6, 2026 | Jessie Hanrahan | Chief Regulatory Officer | Sale | 12.3K | $6.44 | $79.5K |
| Feb 6, 2026 | Paul Herzich | Chief Technology Officer | Sale | 10.9K | $6.44 | $70.2K |
| Feb 3, 2026 | Kevin Tan | CFO & Treasurer | Sale | 26.8K | $6.44 | $172.7K |
| Feb 3, 2026 | Alexander Cumbo | President and CEO | Sale | 80.3K | $6.44 | $516.6K |
| Feb 3, 2026 | Jessie Hanrahan | Chief Regulatory Officer | Sale | 26.5K | $6.44 | $170.8K |
| Feb 3, 2026 | Gabriel Brooks | Chief Medical Officer | Sale | 28.3K | $6.44 | $182.4K |
| Feb 3, 2026 | David T Howton | Chief Operating Officer | Sale | 37.8K | $6.44 | $243.1K |
| Feb 3, 2026 | Paul Herzich | Chief Technology Officer | Sale | 26.3K | $6.44 | $169.0K |
| Jan 30, 2026 | Ilan Ganot | Director | Sale | 191 | $6.59 | $1.3K |
| Jan 13, 2026 | Kevin Tan | CFO & Treasurer | Sale | 5.7K | $5.27 | $30.1K |
| Jan 6, 2026 | Ilan Ganot | Director | Sale | 1.1K | $5.43 | $5.7K |
| Dec 4, 2025 | David T Howton | Chief Operating Officer | Sale | 4.9K | $5.11 | $25.2K |
| Dec 4, 2025 | Alexander Cumbo | President and CEO | Sale | 10.8K | $5.11 | $55.2K |
| Dec 4, 2025 | Jessie Hanrahan | Chief Regulatory Officer | Sale | 4.5K | $5.11 | $22.9K |
Showing the 25 most recent of 96 Form 4 filings for Solid Biosciences Inc..
Most active SLDB insiders
- Ilan Ganot19 filings
- Alexander Cumbo7 filings
- David T Howton7 filings
- Jessie Hanrahan7 filings
- Kevin Tan7 filings
Ask anything about SLDB insider activity
Use Trabud's AI agent to query Solid Biosciences Inc.'s Form 4 history in plain English — "Show me SLDB CEO purchases this year" or compare it against any other ticker.
Open the AI agentSLDB insider trading FAQ
Are Solid Biosciences Inc. insiders buying or selling?
Across 96 SEC Form 4 filings, Solid Biosciences Inc. (SLDB) insiders reported 10 open-market purchases totaling $90.8M and 86 sales totaling $14.2M. That is a net buying position of $76.6M.
How many insiders trade SLDB stock?
22 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Solid Biosciences Inc.. The most recent filing was accepted on Feb 19, 2026.
Where does Trabud get SLDB insider trading data?
All SLDB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.